Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

143
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
143
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

456
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
456

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Impact of immunosuppressive therapy on renal and patient survival in rapidly progressive secondary IgA nephropathy.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Pivotal Clinical Trials in C3 Glomerulopathy: answers and remaining uncertainties.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Advances in therapy·2026
Same author

Short versus long corticosteroid therapy for immune checkpoint inhibitors-induced acute tubulointerstitial nephritis.

Clinical kidney journal·2026
Same author

Chronic kidney disease progression in glomerular diseases: is hematuria a key risk factor?

Pediatric nephrology (Berlin, Germany)·2026
Same author

Extrarenal Disease in ANCA-Associated Vasculitis: Challenges and Evolving Therapeutic Strategies on behalf of the Immunonephrology Working Group (IWG) of the ERA.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026

相关实验视频

Updated: Jul 9, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.9K

在IgA脏病的向补充剂.

Fernando Caravaca-Fontán1, Eduardo Gutiérrez2, Ángel M Sevillano2

  • 1Department of Nephrology, Instituto de Investigación Hospital 12 de Octubre (imas12), Madrid, Spain.

Clinical kidney journal
|December 6, 2023
PubMed
概括
此摘要是机器生成的。

免疫球蛋白A脏病 (IgAN) 涉及补体系统的激活,影响疾病的进展. 向补充通路为这种常见的脏疾病提供了有希望的新疗法.

关键词:
在IgA脏病发作中,IgA脏病发作另一个替代路径路径.莱克通路的路径血栓性微血管病变是一种血栓性微血管病变.

更多相关视频

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K

相关实验视频

Last Updated: Jul 9, 2025

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice
05:39

Detection of MicroRNA Expression in the Kidneys of Immunoglobulin A Nephropathic Mice

Published on: July 8, 2020

1.9K
Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy
14:18

Author Spotlight: Investigating the Potential of Chinese Herbal Medicinal Active Dioscin in Treating IgA Nephropathy

Published on: October 13, 2023

1.8K
Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

2.9K

科学领域:

  • 腎臟病學 (nephrology) 是一種醫學專業.
  • 免疫学 免疫学 免疫学
  • 补充系统生物学 补充系统生物学

背景情况:

  • 免疫球蛋白A脏病 (IgAN) 是全球主要的原发性血球炎的主要原因.
  • 补充系统的激活,特别是替代途径,在IgAN病原和进展中起着至关重要的作用.
  • 与H因子相关的蛋白质和莱克通路激活与IgAN严重性和补充失调有关.

研究的目的:

  • 综合审查补充系统在IGAN病变发生中的作用.
  • 讨论IgAN中补充激活的新兴机制.
  • 突出补充抑制剂的潜力,作为IGAN的新型治疗策略.

主要方法:

  • 对IgAN补充剂激活研究的文献综述.
  • 对补体沉积 (C3,C4d) 和IgAN进展之间的关联进行分析.
  • 审查正在进行的临床试验补充向疗法在IgAN.

主要成果:

  • 淋巴体C3沉积与IGAN疾病进展相关.
  • C4d沉积与组织学活性增加和较差的结局有关.
  • 在IGAN中的血栓式微血管病变表明预后较差.

结论:

  • 了解补充剂在Igan中的作用导致了向治疗的发展.
  • 目前正在研究一些针对不同成分 (B因子,C3,C5,C5aR1) 的补充抑制剂.
  • 补充抑制对IGAN患者来说是一个有前途的治疗途径.